StonvexLoading…
StonvexStonvexStonvexCore line items from ED's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $5.23B | $17.05B | $13.09B | $8.52B |
Operating Income | $1.18B | $2.94B | $2.45B | $1.48B |
Net Income | $924.00M | $2.02B | $1.73B | $246.00M |
EPS (Diluted) | $2.54 | $5.64 | $4.83 | $2.92 |
Total Assets | $74.74B | $74.60B | $71.84B | $71.50B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $147.00M | $1.63B | $181.00M | $1.51B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 364.40M | 361.00M | 357.60M | 355.80M |